s 2160

S 2160 is a synthetic chromogenic substrate for thrombin.

Azalanstat (RS 21607) is an orally available selective mammalian lanosterol 14-alpha-demethylase inhibitor with hypocholesterolemic activity that inhibits cholesterol synthesis in HepG2 cells, human fibroblasts, hamster hepatocytes, and hamster livers through inhibition of the cytochrome P450 enzyme, lanosterol 14 alpha demethylase.

(2R,4S)-Azalanstat (Iso-Azalansta) is a selective heme oxygenase (HO) inhibitor that is used in the study of cardiovascular disease.

Ici D8731 is a nonpeptide angiotensin II antagonist with potential as a treatment for hypertension and heart failure.

BR103 is a metabolically stable C3aR-selective agonist that can be used to assess the ligand affinity of G protein-coupled receptors and to induce paw edema models.